Home » Authors » Anette Breindl

Articles by Anette Breindl

Fighting 'Gang Of Four' Is Uphill Battle, But Success Stories Exist

Dec. 28, 2006

By Anette Breindl and Aaron Lorenzo

More Vasculature Is Less Tumor In Genentech, Regeneron Papers

Dec. 27, 2006

By Anette Breindl

More Vasculature Is Less Tumor In Genentech, Regeneron Papers

Dec. 27, 2006

By Anette Breindl

3D Mouse Brain Map Shows iPods Of Data In Each Gene

Dec. 26, 2006

By Anette Breindl

3D Mouse Brain Map Shows iPods Of Data In Each Gene

Dec. 26, 2006

By Anette Breindl

Exclusive Club' Of Noncoding RNA Now Open To 21U Crowd

Dec. 22, 2006

By Anette Breindl

Exclusive Club' Of Noncoding RNA Now Open To 21U Crowd

Dec. 22, 2006

By Anette Breindl

Research Suggests That For Angiogenesis, It's In The Mix

Dec. 13, 2006

By Anette Breindl

Research Suggests That For Angiogenesis, It's In The Mix

Dec. 13, 2006

By Anette Breindl

At ASH, Third-Generation Kinase Inhibitors For CML

Dec. 12, 2006

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...